OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reprogramming of mitochondrial proline metabolism promotes liver tumorigenesis
Zhaobing Ding, Russell Ericksen, Qian Yi Lee, et al.
Amino Acids (2021) Vol. 53, Iss. 12, pp. 1807-1815
Closed Access | Times Cited: 23

Showing 23 citing articles:

The Multifaceted Roles of Proline in Cell Behavior
Eduardo J. Patriarca, Federica Cermola, Cristina D’Aniello, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 89

Aldehyde dehydrogenase in solid tumors and other diseases: Potential biomarkers and therapeutic targets
Jie Xia, Siqin Li, Suling Liu, et al.
MedComm (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 41

Amino acid metabolism, redox balance and epigenetic regulation in cancer
Xiang Li, Hongsheng Zhang
FEBS Journal (2023) Vol. 291, Iss. 3, pp. 412-429
Open Access | Times Cited: 36

Cooperative STAT3-NFkB signaling modulates mitochondrial dysfunction and metabolic profiling in hepatocellular carcinoma
Sharmeen Ishteyaque, Gurvinder Singh, Karan Singh Yadav, et al.
Metabolism (2024) Vol. 152, pp. 155771-155771
Closed Access | Times Cited: 10

Glutamine metabolic reprogramming in hepatocellular carcinoma
Yanyan Ye, Bodong Yu, Hua Wang, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 13

Novel Fragment Inhibitors of PYCR1 from Docking-Guided X-ray Crystallography
Kaylen Meeks, Juan Ji, M. V. Protopopov, et al.
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 5, pp. 1704-1718
Closed Access | Times Cited: 5

Ancestral bisphenol A exposure led to nonalcoholic fatty liver disease and sex-specific alterations in proline and bile metabolism pathways in the liver
Sourav Chakraborty, Santosh Anand, Muhammad Numan, et al.
Environmental Toxicology and Chemistry (2025)
Closed Access

Discovery of targeting USP10-mediated proline metabolism arrangement to inhibit hepatocellular carcinoma progression
Yinze Han, Weili Kong, Qi‐Xin Shang, et al.
Biochemical Pharmacology (2025), pp. 116904-116904
Closed Access

Mitochondrial fragmentation in liver cancer: Emerging player and promising therapeutic opportunities
Qian Wang, Pengfei Yu, Chaoxu Liu, et al.
Cancer Letters (2022) Vol. 549, pp. 215912-215912
Closed Access | Times Cited: 14

Low-dose radiation exaggerates HFD-induced metabolic dysfunction by gut microbiota through PA-PYCR1 axis
Zhao Ju, Peiyu Guo, Xiang Jing, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 10

Acetaldehyde Dehydrogenases in Liver Zonation and Liver Cancer
Brady Jin-Smith, Natacha Jn‐Simon, Sreenivasulu Basha, et al.
Gene Expression (2023) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 4

Metabolic Alterations in Preneoplastic Development Revealed by Untargeted Metabolomic Analysis
Henna Myllymäki, Jeanette A. Johansson, Estefania Grados Porro, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 8

High levels of Myc expression are required for the robust proliferation of hepatocytes, but not for the sustained weak proliferation
Masanori Goto, Takako Ooshio, Masahiro Yamamoto, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1869, Iss. 4, pp. 166644-166644
Open Access | Times Cited: 2

RNA-Seq Analysis of Glycolysis Regulation of Avian Leukosis Virus Subgroup J Replication
Ting Yang, Lingling Qiu, Shihao Chen, et al.
Animals (2024) Vol. 14, Iss. 17, pp. 2500-2500
Open Access

Advancements in nano drug delivery system for liver cancer therapy based on mitochondria-targeting
Lixia Chen, Yitian He, Jinshuai Lan, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117520-117520
Open Access

Characterization of an Activated Metabolic Transcriptional Program in Hepatoblastoma Tumor Cells Using scRNA-seq
Claudia Monge, Raquel Francés, Agnès Marchio, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 13044-13044
Open Access

Aldehyde dehydrogenases as drug targets for cancer: SAR and structural biology aspects for inhibitor design
Himanshu Tahiliani, Arunkumar Dhayalan, Mu‐Chun Li, et al.
Bioorganic Chemistry (2024) Vol. 154, pp. 108019-108019
Closed Access

Exploring the dynamic three-dimensional chromatin architecture and transcriptional landscape in goose liver tissues underlying metabolic adaptations induced by a high-fat diet
Guangliang Gao, Rui Liu, Silu Hu, et al.
Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology (2024) Vol. 15, Iss. 1
Open Access

Circ_0000705 facilitates proline metabolism of esophageal squamous cell carcinoma cells by targeting miR-621/PYCR1 axis
Cuijuan Qian, Yi-yang Tong, Lin-ken Wu, et al.
Discover Oncology (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 1

Characteristic ASS1 and PYCR1 Maintain Esophageal Squamous Cell Carcinoma Development Under Limited Nutrient Conditions
Kang Fang, Mingchuang Sun, Yuan Chu, et al.
SSRN Electronic Journal (2021)
Closed Access

Page 1

Scroll to top